These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38464145)

  • 1. Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human beta-cardiac myosin allosterically.
    Nandwani N; Bhowmik D; Childers MC; Goluguri RR; Dawood A; Regnier M; Spudich JA; Ruppel KM
    bioRxiv; 2024 Mar; ():. PubMed ID: 38464145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity.
    Adhikari AS; Trivedi DV; Sarkar SS; Song D; Kooiker KB; Bernstein D; Spudich JA; Ruppel KM
    Nat Commun; 2019 Jun; 10(1):2685. PubMed ID: 31213605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Toepfer CN; Garfinkel AC; Venturini G; Wakimoto H; Repetti G; Alamo L; Sharma A; Agarwal R; Ewoldt JK; Cloonan P; Letendre J; Lun M; Olivotto I; Colan S; Ashley E; Jacoby D; Michels M; Redwood CS; Watkins HC; Day SM; Staples JF; Padrón R; Chopra A; Ho CY; Chen CS; Pereira AC; Seidman JG; Seidman CE
    Circulation; 2020 Mar; 141(10):828-842. PubMed ID: 31983222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.
    Kraft T; Montag J
    Pflugers Arch; 2019 May; 471(5):719-733. PubMed ID: 30740621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of force-pCa relation in
    Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice.
    Sitbon YH; Kazmierczak K; Liang J; Yadav S; Veerasammy M; Kanashiro-Takeuchi RM; Szczesna-Cordary D
    FEBS J; 2020 Sep; 287(18):3989-4004. PubMed ID: 32034976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure of the folded-back state of human β-cardiac myosin.
    Grinzato A; Auguin D; Kikuti C; Nandwani N; Moussaoui D; Pathak D; Kandiah E; Ruppel KM; Spudich JA; Houdusse A; Robert-Paganin J
    Nat Commun; 2023 May; 14(1):3166. PubMed ID: 37258552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
    Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
    Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy.
    Kawana M; Sarkar SS; Sutton S; Ruppel KM; Spudich JA
    Sci Adv; 2017 Feb; 3(2):e1601959. PubMed ID: 28246639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.
    Anderson RL; Trivedi DV; Sarkar SS; Henze M; Ma W; Gong H; Rogers CS; Gorham JM; Wong FL; Morck MM; Seidman JG; Ruppel KM; Irving TC; Cooke R; Green EM; Spudich JA
    Proc Natl Acad Sci U S A; 2018 Aug; 115(35):E8143-E8152. PubMed ID: 30104387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Nag S; Trivedi DV; Sarkar SS; Adhikari AS; Sunitha MS; Sutton S; Ruppel KM; Spudich JA
    Nat Struct Mol Biol; 2017 Jun; 24(6):525-533. PubMed ID: 28481356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structure of the folded-back state of human β-cardiac myosin.
    Grinzato A; Auguin D; Kikuti C; Nandwani N; Moussaoui D; Pathak D; Kandiah E; Ruppel KM; Spudich JA; Houdusse A; Robert-Paganin J
    bioRxiv; 2023 Apr; ():. PubMed ID: 37131793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
    Spudich JA
    Pflugers Arch; 2019 May; 471(5):701-717. PubMed ID: 30767072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
    Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
    J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States.
    Gollapudi SK; Ma W; Chakravarthy S; Combs AC; Sa N; Langer S; Irving TC; Nag S
    J Mol Biol; 2021 Nov; 433(23):167295. PubMed ID: 34627791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies.
    Kawana M; Spudich JA; Ruppel KM
    Front Physiol; 2022; 13():975076. PubMed ID: 36225299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.
    Vera CD; Johnson CA; Walklate J; Adhikari A; Svicevic M; Mijailovich SM; Combs AC; Langer SJ; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2019 Nov; 294(46):17451-17462. PubMed ID: 31582565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy.
    McNamara JW; Li A; Lal S; Bos JM; Harris SP; van der Velden J; Ackerman MJ; Cooke R; Dos Remedios CG
    PLoS One; 2017; 12(6):e0180064. PubMed ID: 28658286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light.
    Trivedi DV; Adhikari AS; Sarkar SS; Ruppel KM; Spudich JA
    Biophys Rev; 2018 Feb; 10(1):27-48. PubMed ID: 28717924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Molecular Phenotypes in Point Mutations at the Same Residue in Beta-Myosin Heavy Chain Lead to Distinct Cardiomyopathies.
    Lehman SJ; Meller A; Solieva SO; Lotthammer JM; Greenberg L; Langer SJ; Greenberg MJ; Tardiff JC; Bowman GR; Leinwand L
    bioRxiv; 2023 Jul; ():. PubMed ID: 37461648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.